Recent

% | $
Quotes you view appear here for quick access.

Geron Corporation (GERN) Message Board

  • gosmokeadoobie gosmokeadoobie Dec 22, 2012 12:15 PM Flag

    imetelstat

    imetelstat is a man made "short chain" of molecules. this short chain is a strand of DNA. telomerase is an enzyme. cancer cells contain large amounts of this enzyme. telemeres feed off of this enzyme. imetelstat attaches to the telomerase enzyme and this bond prevents short length telemeres from consuming this enzyme. without the needed telomerase enzyme to feed on these telemeres starve to death and thus kills the cancer cell.

    the key to this action is the length of the telemeres. the shorter the length the more effective imetelstat is in inhibiting cancer cells. in fact, imetelstat has been shown to be amazingly effective against cancers with the shortest of telemeres—hematological cancers.

    in short, geron is going to become a very valuable company.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • lenprov8 - Professor Elizabeth Blackburn who co-discovered telomerase, the enzyme that replenishes telomeres has created a company — Telome Health, Inc. — along with former geron vice president of reasearch Calvin Harley. THI will provide telomere length data from tissue samples for academic research, pharmaceutical drug development, and health monitoring.

      Sentiment: Strong Buy

    • lenprov8 - Professor Elizabeth Blackburn who co-discovered telomerase, the enzyme that replenishes telomeres has created a company — Telome Health, Inc. — along with former geron vice president of reasearch Calvin Harley. THI will provide telomere length data from tissue samples for academic research, pharmaceutical drug development, and health monitoring.

      Sentiment: Strong Buy

    • Their latest clinical results looked very good. I bought some GERN stock for first time. Imetelstat looks like a winner. Mgmt there must be confident, as they dumped the rest of the pipeline and are now wholly focused on this one drug. It should pay off for them....finally.....

    • What are the stats on short telomeres .. Is testing possible. Are they more common in certain cancers... Besides hematologiaca, sounds good.

      Sentiment: Buy

    • Is this a promise? (By the way, don't Bogart that joint.)

      Sentiment: Strong Buy

 
GERN
3.885+0.005(+0.13%)May 6 4:00 PMEDT